Ali Özdemir, Dilek Doğruel, Aydın Yücel, Armağan Api

Persistan plevral efüzyonu olan infant olgunun talk plörodezis ile tedavisi

Plevral efüzyon, plevral kavitede belirgin sıvı birikmesi olarak tanımlanır. Genellikle enfeksiyöz ajanlarla oluşur. Diğer etmenler arasında konjestif kalp hastalıkları, maligniteler, viral hastalıklar, travma, hipoalbuminemi, bağ doku hastalıkları ve kromozomal hastalıklar sayılabilir. Tedavi sorumlu etmene göre yapılır. Bu yazıda komplike olmayan Morgagni hernisi cerrahisi sonucu persistan plevral efüzyon gelişen 16 aylık erkek olgu sunuldu. Antibiyoterapi, parenteral beslenme desteği ve oktreotid tedavilerine yanıt alınamaması üzerine çocuk cerrahisi tarafından talk plörodezisi uygulanan olgumuzun başarılı bir şekilde tedavisi sağlandı ve bir sklerozan ajan olan talk uygulamanın herhangi bir yan etkisi gözlenmedi. Pediatrik yaş grubunda plevral efüzyon tedavisinde nadir bir uygulama olan plörodezisi bu olguda uygulanmıştır.

Anahtar Kelimeler:

Morgagni hernisi, plevral efüzyon, talk plörodezis

Talc pleurodesis in the management of persistent pleural effusion in an infant

Pleural effusion is excessive fluid that accumulates in the pleural cavity. It predominantly occurs by infectious agents. Other various causes include congestive heart diseases, malignancies, viral diseases, trauma, hypoalbuminemia, connective tissue diseases and chromosomal abnormalities. Treatment strategies should target the responsible cause. Herein, we present a 16-month old male infant with persistent pleural effusion occuring after uncomplicated Morgagni hernia surgery who had no response to antibiotics, parenteral nutritional support and octreotide therapy that was eventually treated by pediatric surgery with talc pleurodesis. No significant advers effect was observed after administration of talc as a sclerozing agent for pleurodesis. This procedure has been rarely reported at this age group.

PDF

___

Tokur M, Ergin M, Demiröz M, Girişgin AS. Approach to pleural effusions in the emergency department. The Journal of Academic Emergency Medicine. 2013;12:155-63.
Efrati O, Barak A. Pleural effusions in the pediatric population. Pediatr Rev. 2002;23:417- 26.
Vargas FS, Milanez JR, Filameno LT, Fernandez A, Jatene A, Light RW. Intrapleural talc for the prevention of recurrent pneumothorax. Chest. 1994;106:1162-5.
Vargas FS, Milanez JR, Filameno LT, Fernandez A, Jatene A, Light RW.. Intrapleural talc for the prevention underdiagnosed 1994;106:1771-5. in effusions. Chest.
Tansel T, Sayın OA, Uğuranlı M, Dayioglu E, Onursal E. Successful bleomycin pleurodesis in a patient with prolonged pleural effusion after extracardiac fontan procedure. J Card Surg. 2006;21:585-6.
Hoffer FA, Hancock MI, Hinds PS, Oigbokie N, Rai SN, Rao B. Pleurodesis for effusions in pediatric oncology patients at end of life. Pediatr Radiol. 2007;37:269-73.
Lee YC, Bauman MH, Maskell NA, Waterer GW, Eaton TE, Davies RJ et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest. 2003;124:2229- 38.